Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis
about
Treating inflammatory bowel disease by adsorptive leucocytapheresis: a desire to treat without drugs.Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresisEmerging drugs for the treatment of ulcerative colitisTherapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.Cytapheresis in inflammatory bowel diseases: current evidence and perspectives.Value of colonoscopy for prediction of prognosis in patients with ulcerative colitisLeukocytapheresis for the treatment of IBD.Leukocyte apheresis in the management of ulcerative colitis.Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis.Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry.Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.Granulocytapheresis versus methylprednisolone in patients with acute ulcerative colitis: 12-month follow up.Treatment options for children and adolescents with inflammatory bowel disease: is granulomonocytapheresis an effective alternative to drug therapy?Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.A multi center study of granulocyte and monocyte adsorption apheresis therapy for ulcerative colitis-clinical efficacy and production of interleukin-1 receptor antagonist.
P2860
Q34008773-DC803D35-211A-4F40-9830-D8D136AE9C4DQ34831143-58F0EB00-3178-4E40-B04C-FCB3A5316181Q36039436-79F99E6D-1194-4783-80FB-6401ACAE5929Q36522931-BA0BB96D-09F0-45B5-BDF1-B8ACE82BF7DAQ37114622-2938A667-15D4-4C02-AD7F-53F7F6EC2C64Q37125624-50FB5371-BC5C-4B2C-B998-37A78F920B24Q37136938-A62AADE5-0C9E-4424-97FF-7EF66B50AA36Q37229788-314649DA-EB72-4C82-97E0-D68526659491Q41992829-03BE967A-80A0-4B21-82EF-49231CA9E2ADQ42167021-C83C830B-8F60-403A-BE92-6380C14CD837Q42625889-1F0B0C29-67C7-4D2C-AEF1-351726350F14Q42726307-B7438DA8-2205-438A-9B90-98920689CE60Q46341671-8BE4DB58-B1D8-4340-8182-B8C929253BF1Q47694487-DB4A1325-C896-437D-ACB8-82A4B758F653Q48071894-029BAED0-873A-4E35-9421-80D5F8EA2AABQ53479943-6B878CFF-7730-4DF3-9C8D-DFFF13DCCB7F
P2860
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Open label trial of granulocyt ...... refractory ulcerative colitis
@ast
Open label trial of granulocyt ...... refractory ulcerative colitis
@en
type
label
Open label trial of granulocyt ...... refractory ulcerative colitis
@ast
Open label trial of granulocyt ...... refractory ulcerative colitis
@en
prefLabel
Open label trial of granulocyt ...... refractory ulcerative colitis
@ast
Open label trial of granulocyt ...... refractory ulcerative colitis
@en
P2093
P2860
P356
P1476
Open label trial of granulocyt ...... refractory ulcerative colitis
@en
P2093
Alberto Malesci
Joachim Mössner
Julia Morgenstern
Maurizio Vecchi
Max Reinshagen
Robert Löfberg
Stephan Schreiber
Wolfgang Kruis
P2860
P304
P356
10.3748/WJG.V11.I44.7001
P407
P577
2005-11-01T00:00:00Z